Fortis Healthcare Ltd

NSE : FORTIS14 Jan 2025

Healthcare

₹

+0.80 (+0.12%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Fortis Healthcare Ltd

Fortis Healthcare Ltd

Healthcare

NSE : FORTIS14 Jan 2025

₹

+0.80 (+0.12%)

OverviewFundamentals

Corporate action

Peer comparison

Cash flow

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date	Ratio
23-May-2024	D	Dividend: Considered and recommended final dividend of ?1 per equity share (10% of face value of ?10 /- each), for the financial year 2023-24, subject to approval of the members of the Company, which shall be paid/ dispatched within 30 days from the conclusion of the ensuing Annual General Meeting, if approved.	24-Jul-2024
24-May-2023	D	This is to inform you that the Board of Directors of the Company at its meeting held today i.e. May 23, 2023, inter-alia, has: a)Considered and approved the standalone and consolidated audited financial results of the Company for the quarter and financial year ended on March 31, 2023. M/s B S R and Co. LLP, the Statutory Auditors of the Company have issued an Audit Report with unmodified opinion. b) Considered and recommended a final dividend of ? 1 /- per equity share (10% of face value of ? 10 /- each), for the financial year 2022-23, subject to approval of the members of the Company, which shall be paid/ dispatched within 30 days from the conclusion of the ensuing Annual General Meeting. The Company has fixed July 20, 2023 as Record Date for the purpose of payment of final dividend, subject to the approval of the shareholders in the Annual General Meeting scheduled to be held on August 1, 2023. Detailed disclosure in this regard is enclosed herewith. (As Per BSE Announcement dated on 30.06.2023)	20-Jul-2023
12-Aug-2009	R	SUB. :- Rights issue of Fortis Healthcare Limited (Scrip Code 532843) Trading Members of the Exchange are hereby informed that, Fortis Healthcare Limited has fixed the Record Date for the purpose of Rights Issue. The transactions in the equity shares of the company should be done on ex-rights basis with effect from the under mentioned date. DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT COMPANY NAME CODE Fortis Healthcare Limited (532843) RECORD DATE 20/08/2009 PURPOSE Issue of 2 (TWO) Equity Shares of Rs.10/- each for cash at a premium of Rs.100/- per share on rights basis for every 5 (FIVE) existing fully paid up equity shares of Rs.10/- each held TRANSACTIONS IN EQUITY SHARES ON Cum-Right basis up to Date & Sett. No. 17/08/2009 DR-095/2009-2010 Ex-Right basis from Date & Sett. No. 18/08/2009 DR-096/2009-2010 Trading Members of the Exchange are requested to refer the annexure to this notice for the terms of Rights Issue.	20-Aug-2009	2:5
12-Aug-2009	R	SUB. :- Rights issue of Fortis Healthcare Limited (Scrip Code 532843) Trading Members of the Exchange are hereby informed that, Fortis Healthcare Limited has fixed the Record Date for the purpose of Rights Issue. The transactions in the equity shares of the company should be done on ex-rights basis with effect from the under mentioned date. DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT COMPANY NAME CODE Fortis Healthcare Limited (532843) RECORD DATE 20/08/2009 PURPOSE ONE Series A detachable warrant and ONE Series B detachable warrant for every 2 (TWO) equity shares allotted in the issue. TRANSACTIONS IN EQUITY SHARES ON Cum-Right basis up to Date & Sett. No. 17/08/2009 DR-095/2009-2010 Ex-Right basis from Date & Sett. No. 18/08/2009 DR-096/2009-2010 Trading Members of the Exchange are requested to refer the annexure to this notice for the terms of Rights Issue.	20-Aug-2009	2:2
05-Jul-2024	BC	Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations') read with SEBI Circular dated July 13, 2023, this is to inform you th	19-Mar-2025
27-Dec-2024	BC	Outcome of the Board Meeting-December 27, 2024 Relevant disclosure is attached.	27-Dec-2024
27-Dec-2024	BC	Outcome of the Board Meeting-December 27, 2024 Relevant Disclosure is attached.	27-Dec-2024
20-Dec-2024	BC	Agilus Diagnostics Limited	20-Dec-2024
24-Dec-2024	BC	Aditya Birla Sun Life Mutual Fund	20-Dec-2024

Record Date01 Jan'1900

Ex-Rights Date01 Jan'1900

Premium(Rs.)100

Ratio2:5

Record Date01 Jan'1900

Ex-Rights Date01 Jan'1900

Premium(Rs.)0

Ratio2:2

Book Closure

Record Date	Split Date	Purpose
19-Mar-2025	-	Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations') read with SEBI Circular dated July 13, 2023, this is to inform you th
27-Dec-2024	-	Outcome of the Board Meeting-December 27, 2024 Relevant disclosure is attached.
27-Dec-2024	-	Outcome of the Board Meeting-December 27, 2024 Relevant Disclosure is attached.
20-Dec-2024	-	Agilus Diagnostics Limited
20-Dec-2024	-	Aditya Birla Sun Life Mutual Fund

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Fortis Healthcare Ltd ₹663.55(+0.80/0.12%)	663.55	+0.80	50,095.25	60.20	264.40	5.52
Poly Medicure Ltd ₹2,556.30(-42.85/-1.65%)	2,556.30	-42.85	25,901.89	75.93	88.79	10.05
Syngene International Ltd ₹827.50(+4.75/0.58%)	827.50	+4.75	33,309.94	12.72	75.92	7.72
Indegene Ltd ₹632.75(+29.40/4.87%)	632.75	+29.40	15,139.74	10.83	97.03	8.54
GPT Healthcare Ltd ₹172.82(+5.79/3.47%)	172.82	+5.79	1,418.07	-9.90	28.96	6.15
Shalby Ltd ₹221.34(+6.87/3.20%)	221.34	+6.87	2,390.69	-26.66	25.26	2.19

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Cash and Cash Equivalents at Beginning of the year	-12.18	-19.75	-14.16	-80.42	-18.85
Net Cash from Operating Activities	218.45	198.38	76.49	31.94	99.92
Net Cash Used In Investing Activities	44.46	204.62	237.74	28.40	810.04
Net Cash Used In Financing Activities	-245.35	-395.43	-319.83	5.91	-971.53
Net Inc./Dec In Cash And Cash Equivalents	17.56	7.57	-5.60	66.26	-61.57
Cash And Cash Equivalents At End Of The Year	5.37	-12.18	-19.75	-14.16	-80.42

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

31.17%

FII Shareholding

25.26%

DII Shareholding

30.74%

Public Shareholding

12.84%

**Promoter pledged shareholding 31.17%

About Fortis Healthcare Ltd

Fortis Healthcare Ltd is in the Healthcare sector, having a market capitalization of Rs. 50102.8 crores. It has reported a sales of Rs. 357.15 crores and a net profit of Rs. 39.63 crores for the quarter ended December 2018. The company management includes Leo Puri, Suvalaxmi Chakraborty,Indrajit Banerjee,Ashutosh Raghuvanshi,Shailaja Chandra,DILIP KADAMBI,Tomo Nagahiro,Mehmet Ali Aydinlar,Lim Tsin Lin,Satyendra Chauhan,Prem Kumar Nair,Ashok Pandit,Leo Puri (Fortis Healthcare Ltd) among others.

Chairman

Leo Puri

Registered office

Fortis Hospital Sector-62,Phase-VIII,Mohali,Punjab,160062

FAX :91-172-5096001

Background

Incorporation Year1996

Face Value₹10

Market Lot1